HIV is a serious illness that affects more than two million people in the United States. There’s lots of new research into HIV treatment and prevention, but some of the most promising treatments and cures are still years away from entering clinical trials.
HIV affects more than two million people in the United States.
HIV is a virus that attacks the immune system, leading to a range of health problems and disease. It’s transmitted through bodily fluids such as blood, semen and vaginal fluids—and can also be transmitted through unprotected sex with an infected partner.
HIV is most common in black Americans and Hispanics/Latinos, but it affects everyone who has sex with someone who has HIV regardless of race/ethnicity or sexual orientation. In fact, 1 in 75 Americans will get diagnosed with HIV at some point in their life (1).
There are many ways to become infected with HIV: needle sharing between injection drug users (IDUs), unsafe injections at sites other than medical facilities (i.e., dirty needles), having unprotected sex without discussing condom use with your partner(s) and sharing razors etc., among others
There’s lots of new research into HIV treatment and prevention
There are many new drugs in development and trials. Some of these drugs target HIV at the genetic level, others target it at the cellular level, and still others may target it at both levels.
New medications such as dolutegravir can prevent HIV from replicating in the body
Dolutegravir is a medication that prevents HIV from replicating, making it one of the most effective anti-HIV drugs. It’s taken daily and can be used in combination with other medications.
Dolutegravir (Truvada) is a pill, so it’s easy to take: just swallow it with water or crush up the pills before swallowing them whole.
A new range of drugs called PrEP is available that blocks the transmission of HIV from person-to-person
A new range of drugs called PrEP is available that blocks the transmission of HIV from person-to-person. It provides a level of protection against HIV infection that is more than 99% effective, but it’s only prescribed for people who are at high risk of getting infected with HIV. This includes gay and bisexual men who have sex with other gay men (MSMWs), people who inject drugs (PWIDs), and their partners.
PrEP can help reduce the number of new infections in these high-risk groups if taken every day as directed. The medication works by preventing viruses from being released into your bloodstream after taking an oral dose at least once a week over 96 hours—the time it takes for your body to get rid of them naturally without any help from medicine or other interventions such as condoms or abstinence programs
Doctors also hope to develop a cure for HIV by using genetic engineering to rewrite the virus’ code
Genetic engineering is a process that involves replacing the genetic code of one organism with that of another. The new gene will then be passed on to future generations, making it possible to treat diseases in humans. For example, scientists have successfully used genetic engineering to create vaccines against malaria and dengue fever. However, there are ethical issues surrounding these treatments because they involve modifying an organism’s DNA—a change that may have unintended consequences down the road (such as letting mosquitoes develop resistance).
Cures vs vaccines: What’s the difference?
A cure for HIV could be considered a vaccine because it treats symptoms rather than preventing infection altogether; however, curing this disease would require more work than creating a vaccine does (since vaccines only need to contain live viruses). As such, many people argue that curing HIV is less effective than developing an effective vaccine would be if done properly; some even argue against using any type of biological therapy at all!
New drugs target HIV at many levels and have shown promise in treating and preventing it
New drugs target HIV at many levels and have shown promise in treating and preventing it.
Dolutegravir is a new drug that can prevent HIV from replicating in the body. It’s given as a pill to people with HIV who haven’t yet developed full-blown AIDS but still have symptoms of the disease. It’s been shown to reduce the risk of transmitting HIV to others by up to 99%. PrEP, or pre-exposure prophylaxis, provides protection against acquiring HIV through sexual activity without taking pills daily (which isn’t recommended). A new class of drugs called Regimens are being developed that may be able to cure AIDS altogether; they’re currently being tested on humans in clinical trials around the world! These two approaches represent significant advancements for people living with HIV/AIDS: they offer hope not only for those currently suffering but also for future generations who could benefit greatly from these treatments.”
So now that you know more about the new HIV treatment options, what should you do? We believe that it’s important to have an open dialogue with your doctor about your health and how they can help you stay as healthy as possible. If there’s one thing we’ve learned from all this information, it’s that staying informed is key!